UCF patented on induced pluripotent stem cells, iPS cells

December 22, 2011
A process that prompts a single gene to generate millions of supercharged stem cells has been patented at UCF. “This technology has the potential of literally changing the entire landscape of regenerative medicine,” said Kiminobu Sugaya, the lead researcher and a professor at UCF’s College of Medicine. “This technology demonstrates the ability to use a patient’s own cells for treatment of a wide range of illness, injury or disease.” Credit: UCF

A process that prompts a single gene to generate millions of supercharged stem cells, which can then turn into any kind of cell a body needs to repair itself, has been patented at the University of Central Florida.

Stem cells have long been regarded as a of sorts in the medical world, because they hold so much potential for treating and perhaps curing some of the most challenging diseases in our time, such as Alzheimer's,Parkinson's and diabetes.

But a limited supply of and associated with cells from embryonic donors have stalled progress on many fronts. For the past decade, researchers around the world have tried to generate embryonic-like stem cells from adult donors. To achieve stem cells this way, several have been required. And many of those genes have been known to trigger cancer. UCF's approach, called Induced pluripotent stem (iPS) , minimizes the risk because only one gene (Nanog) is used in the process.

A study described in Science noted that the gene, which had not been used by others, is not linked to cancer.

"This technology has the potential of literally changing the entire landscape of regenerative medicine," said Kiminobu Sugaya, the lead researcher and a professor at UCF's College of Medicine. "This technology demonstrates the ability to use a patient's own cells for treatment of a wide range of illness, injury or disease."

Sugaya has been investigating the potential use of stem cells in treating Alzheimer's disease for years. He holds dozens of patents including the one for this iPS technology, which was recently licensed to Progenicyte, an emerging Sugaya founded in 2008. Sugaya and Progenicyte will now begin extensive collaborate efforts to advance this new technology from the lab to the treatment of patients.

With better access to stem cells, scientists may be able to open the body's healing power more quickly, giving Alzheimer, Parkinson, diabetes, cancer and heart disease patients hope that their own cells may help them get rid of these diseases, Sugaya said.

Explore further: Stem cells reverse disease in a model of Parkinson's disease

Related Stories

Stem cells reverse disease in a model of Parkinson's disease

May 16, 2011

In a new study to be published in the Journal of Clinical Investigation, researchers compared the ability of cells derived from different types of human stem cell to reverse disease in a rat model of Parkinson disease and ...

Stem cells, potential source of cancer-fighting T cells

September 20, 2011

Adult stem cells from mice converted to antigen-specific T cells -- the immune cells that fight cancer tumor cells -- show promise in cancer immunotherapy and may lead to a simpler, more efficient way to use the body's immune ...

Recommended for you

Flu study, on hold, yields new vaccine technology

September 2, 2015

Vaccines to protect against an avian influenza pandemic as well as seasonal flu may be mass produced more quickly and efficiently using technology described today by researchers at the University of Wisconsin-Madison in the ...

We've all got a blind spot, but it can be shrunk

August 31, 2015

You've probably never noticed, but the human eye includes an unavoidable blind spot. That's because the optic nerve that sends visual signals to the brain must pass through the retina, which creates a hole in that light-sensitive ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.